Management of primary resistance to gemcitabine and cisplatin (G-C) chemotherapy in metastatic bladder cancer with HER2 over-expression.
about
Management of primary resistance to gemcitabine and cisplatin (G-C) chemotherapy in metastatic bladder cancer with HER2 over-expression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Management of primary resistan ...... cer with HER2 over-expression.
@en
Management of primary resistance to gemcitabine and cisplatin
@nl
type
label
Management of primary resistan ...... cer with HER2 over-expression.
@en
Management of primary resistance to gemcitabine and cisplatin
@nl
prefLabel
Management of primary resistan ...... cer with HER2 over-expression.
@en
Management of primary resistance to gemcitabine and cisplatin
@nl
P2093
P356
P1433
P1476
Management of primary resistan ...... cer with HER2 over-expression.
@en
P2093
A Viellefond
D Amsellem-Ouazana
M Peyromaure
P Beuzeboc
P356
10.1093/ANNONC/MDH112
P577
2004-03-01T00:00:00Z